Pre-order Enquiry
Request Free Sample
Global Vaccine Market Research Report 2023
SKU ID : QYR-23311409 | Publishing Date : 28-Mar-2023 | No. of pages : 107
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Vaccine Market Research Report 2023
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Varicella Vaccine
1.2.3 Influenza Vaccine
1.2.4 Polio Vaccine
1.2.5 Hepatitis A Vaccine
1.2.6 Rabies Vaccine
1.2.7 BCG Vaccine
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market by Application
1.3.1 Global Vaccine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 For Adult
1.3.3 For Child
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Market Perspective (2018-2029)
2.2 Vaccine Growth Trends by Region
2.2.1 Global Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Vaccine Market Dynamics
2.3.1 Vaccine Industry Trends
2.3.2 Vaccine Market Drivers
2.3.3 Vaccine Market Challenges
2.3.4 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Players by Revenue
3.1.1 Global Top Vaccine Players by Revenue (2018-2023)
3.1.2 Global Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Revenue
3.4 Global Vaccine Market Concentration Ratio
3.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2022
3.5 Vaccine Key Players Head office and Area Served
3.6 Key Players Vaccine Product Solution and Service
3.7 Date of Enter into Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Breakdown Data by Type
4.1 Global Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Vaccine Forecasted Market Size by Type (2024-2029)
5 Vaccine Breakdown Data by Application
5.1 Global Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Vaccine Market Size (2018-2029)
6.2 North America Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Vaccine Market Size by Country (2018-2023)
6.4 North America Vaccine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Market Size (2018-2029)
7.2 Europe Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Vaccine Market Size by Country (2018-2023)
7.4 Europe Vaccine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Vaccine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Vaccine Market Size by Region (2018-2023)
8.4 Asia-Pacific Vaccine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Market Size (2018-2029)
9.2 Latin America Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Vaccine Market Size by Country (2018-2023)
9.4 Latin America Vaccine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Vaccine Market Size by Country (2018-2023)
10.4 Middle East & Africa Vaccine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Vaccine Introduction
11.1.4 AstraZeneca Revenue in Vaccine Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Detail
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Vaccine Introduction
11.2.4 BioNTech Revenue in Vaccine Business (2018-2023)
11.2.5 BioNTech Recent Development
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Detail
11.3.2 Boehringer-Ingelheim Business Overview
11.3.3 Boehringer-Ingelheim Vaccine Introduction
11.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2018-2023)
11.3.5 Boehringer-Ingelheim Recent Development
11.4 CCBIO
11.4.1 CCBIO Company Detail
11.4.2 CCBIO Business Overview
11.4.3 CCBIO Vaccine Introduction
11.4.4 CCBIO Revenue in Vaccine Business (2018-2023)
11.4.5 CCBIO Recent Development
11.5 CSL
11.5.1 CSL Company Detail
11.5.2 CSL Business Overview
11.5.3 CSL Vaccine Introduction
11.5.4 CSL Revenue in Vaccine Business (2018-2023)
11.5.5 CSL Recent Development
11.6 CureVac
11.6.1 CureVac Company Detail
11.6.2 CureVac Business Overview
11.6.3 CureVac Vaccine Introduction
11.6.4 CureVac Revenue in Vaccine Business (2018-2023)
11.6.5 CureVac Recent Development
11.7 Elanco
11.7.1 Elanco Company Detail
11.7.2 Elanco Business Overview
11.7.3 Elanco Vaccine Introduction
11.7.4 Elanco Revenue in Vaccine Business (2018-2023)
11.7.5 Elanco Recent Development
11.8 GSK
11.8.1 GSK Company Detail
11.8.2 GSK Business Overview
11.8.3 GSK Vaccine Introduction
11.8.4 GSK Revenue in Vaccine Business (2018-2023)
11.8.5 GSK Recent Development
11.9 Hulan Bio
11.9.1 Hulan Bio Company Detail
11.9.2 Hulan Bio Business Overview
11.9.3 Hulan Bio Vaccine Introduction
11.9.4 Hulan Bio Revenue in Vaccine Business (2018-2023)
11.9.5 Hulan Bio Recent Development
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Detail
11.10.2 Indian Immunologicals Business Overview
11.10.3 Indian Immunologicals Vaccine Introduction
11.10.4 Indian Immunologicals Revenue in Vaccine Business (2018-2023)
11.10.5 Indian Immunologicals Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Vaccine Introduction
11.11.4 Merck Revenue in Vaccine Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Detail
11.12.2 Minhai Biotechnology Business Overview
11.12.3 Minhai Biotechnology Vaccine Introduction
11.12.4 Minhai Biotechnology Revenue in Vaccine Business (2018-2023)
11.12.5 Minhai Biotechnology Recent Development
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Detail
11.13.2 Mitsubishi Tanabe Pharma Business Overview
11.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction
11.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2018-2023)
11.13.5 Mitsubishi Tanabe Pharma Recent Development
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Detail
11.14.2 Moderna Therapeutics Business Overview
11.14.3 Moderna Therapeutics Vaccine Introduction
11.14.4 Moderna Therapeutics Revenue in Vaccine Business (2018-2023)
11.14.5 Moderna Therapeutics Recent Development
11.15 Mylan
11.15.1 Mylan Company Detail
11.15.2 Mylan Business Overview
11.15.3 Mylan Vaccine Introduction
11.15.4 Mylan Revenue in Vaccine Business (2018-2023)
11.15.5 Mylan Recent Development
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Detail
11.16.2 Plumbline Life Sciences Business Overview
11.16.3 Plumbline Life Sciences Vaccine Introduction
11.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2018-2023)
11.16.5 Plumbline Life Sciences Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Detail
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Vaccine Introduction
11.17.4 Sanofi Revenue in Vaccine Business (2018-2023)
11.17.5 Sanofi Recent Development
11.18 Translate Bio
11.18.1 Translate Bio Company Detail
11.18.2 Translate Bio Business Overview
11.18.3 Translate Bio Vaccine Introduction
11.18.4 Translate Bio Revenue in Vaccine Business (2018-2023)
11.18.5 Translate Bio Recent Development
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Detail
11.19.2 Walvax Biotechnology Business Overview
11.19.3 Walvax Biotechnology Vaccine Introduction
11.19.4 Walvax Biotechnology Revenue in Vaccine Business (2018-2023)
11.19.5 Walvax Biotechnology Recent Development
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Detail
11.20.2 Wuhan Institute of Biological Products Business Overview
11.20.3 Wuhan Institute of Biological Products Vaccine Introduction
11.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2018-2023)
11.20.5 Wuhan Institute of Biological Products Recent Development
11.21 Zoties
11.21.1 Zoties Company Detail
11.21.2 Zoties Business Overview
11.21.3 Zoties Vaccine Introduction
11.21.4 Zoties Revenue in Vaccine Business (2018-2023)
11.21.5 Zoties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Vaccine Market Research Report 2023
List of TablesTable 1. Global Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Varicella Vaccine
Table 3. Key Players of Influenza Vaccine
Table 4. Key Players of Polio Vaccine
Table 5. Key Players of Hepatitis A Vaccine
Table 6. Key Players of Rabies Vaccine
Table 7. Key Players of BCG Vaccine
Table 8. Key Players of Hepatitis B
Table 9. Key Players of Pertussis, Diphtheria, Tetanus
Table 10. Key Players of Pneumococcal
Table 11. Key Players of Others
Table 12. Global Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 13. Global Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Vaccine Market Share by Region (2018-2023)
Table 16. Global Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Vaccine Market Share by Region (2024-2029)
Table 18. Vaccine Market Trends
Table 19. Vaccine Market Drivers
Table 20. Vaccine Market Challenges
Table 21. Vaccine Market Restraints
Table 22. Global Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Vaccine Market Share by Players (2018-2023)
Table 24. Global Top Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2022)
Table 25. Ranking of Global Top Vaccine Companies by Revenue (US$ Million) in 2022
Table 26. Global 5 Largest Players Market Share by Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Vaccine Product Solution and Service
Table 29. Date of Enter into Vaccine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Vaccine Revenue Market Share by Type (2018-2023)
Table 33. Global Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 34. Global Vaccine Revenue Market Share by Type (2024-2029)
Table 35. Global Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Vaccine Revenue Market Share by Application (2018-2023)
Table 37. Global Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 38. Global Vaccine Revenue Market Share by Application (2024-2029)
Table 39. North America Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. North America Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 42. Europe Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 45. Asia-Pacific Vaccine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 46. Asia-Pacific Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 47. Asia-Pacific Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 48. Latin America Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Latin America Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 50. Latin America Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 51. Middle East & Africa Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 52. Middle East & Africa Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 53. Middle East & Africa Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 54. AstraZeneca Company Detail
Table 55. AstraZeneca Business Overview
Table 56. AstraZeneca Vaccine Product
Table 57. AstraZeneca Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 58. AstraZeneca Recent Development
Table 59. BioNTech Company Detail
Table 60. BioNTech Business Overview
Table 61. BioNTech Vaccine Product
Table 62. BioNTech Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 63. BioNTech Recent Development
Table 64. Boehringer-Ingelheim Company Detail
Table 65. Boehringer-Ingelheim Business Overview
Table 66. Boehringer-Ingelheim Vaccine Product
Table 67. Boehringer-Ingelheim Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 68. Boehringer-Ingelheim Recent Development
Table 69. CCBIO Company Detail
Table 70. CCBIO Business Overview
Table 71. CCBIO Vaccine Product
Table 72. CCBIO Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 73. CCBIO Recent Development
Table 74. CSL Company Detail
Table 75. CSL Business Overview
Table 76. CSL Vaccine Product
Table 77. CSL Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 78. CSL Recent Development
Table 79. CureVac Company Detail
Table 80. CureVac Business Overview
Table 81. CureVac Vaccine Product
Table 82. CureVac Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 83. CureVac Recent Development
Table 84. Elanco Company Detail
Table 85. Elanco Business Overview
Table 86. Elanco Vaccine Product
Table 87. Elanco Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 88. Elanco Recent Development
Table 89. GSK Company Detail
Table 90. GSK Business Overview
Table 91. GSK Vaccine Product
Table 92. GSK Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 93. GSK Recent Development
Table 94. Hulan Bio Company Detail
Table 95. Hulan Bio Business Overview
Table 96. Hulan Bio Vaccine Product
Table 97. Hulan Bio Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 98. Hulan Bio Recent Development
Table 99. Indian Immunologicals Company Detail
Table 100. Indian Immunologicals Business Overview
Table 101. Indian Immunologicals Vaccine Product
Table 102. Indian Immunologicals Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 103. Indian Immunologicals Recent Development
Table 104. Merck Company Detail
Table 105. Merck Business Overview
Table 106. Merck Vaccine Product
Table 107. Merck Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 108. Merck Recent Development
Table 109. Minhai Biotechnology Company Detail
Table 110. Minhai Biotechnology Business Overview
Table 111. Minhai Biotechnology Vaccine Product
Table 112. Minhai Biotechnology Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 113. Minhai Biotechnology Recent Development
Table 114. Mitsubishi Tanabe Pharma Company Detail
Table 115. Mitsubishi Tanabe Pharma Business Overview
Table 116. Mitsubishi Tanabe Pharma Vaccine Product
Table 117. Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 118. Mitsubishi Tanabe Pharma Recent Development
Table 119. Moderna Therapeutics Company Detail
Table 120. Moderna Therapeutics Business Overview
Table 121. Moderna Therapeutics Vaccine Product
Table 122. Moderna Therapeutics Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 123. Moderna Therapeutics Recent Development
Table 124. Mylan Company Detail
Table 125. Mylan Business Overview
Table 126. Mylan Vaccine Product
Table 127. Mylan Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 128. Mylan Recent Development
Table 129. Plumbline Life Sciences Company Detail
Table 130. Plumbline Life Sciences Business Overview
Table 131. Plumbline Life Sciences Vaccine Product
Table 132. Plumbline Life Sciences Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 133. Plumbline Life Sciences Recent Development
Table 134. Sanofi Company Detail
Table 135. Sanofi Business Overview
Table 136. Sanofi Vaccine Product
Table 137. Sanofi Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 138. Sanofi Recent Development
Table 139. Translate Bio Company Detail
Table 140. Translate Bio Business Overview
Table 141. Translate Bio Vaccine Product
Table 142. Translate Bio Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 143. Translate Bio Recent Development
Table 144. Walvax Biotechnology Company Detail
Table 145. Walvax Biotechnology Business Overview
Table 146. Walvax Biotechnology Vaccine Product
Table 147. Walvax Biotechnology Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 148. Walvax Biotechnology Recent Development
Table 149. Wuhan Institute of Biological Products Company Detail
Table 150. Wuhan Institute of Biological Products Business Overview
Table 151. Wuhan Institute of Biological Products Vaccine Product
Table 152. Wuhan Institute of Biological Products Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 153. Wuhan Institute of Biological Products Recent Development
Table 154. Zoties Company Detail
Table 155. Zoties Business Overview
Table 156. Zoties Vaccine Product
Table 157. Zoties Revenue in Vaccine Business (2018-2023) & (US$ Million)
Table 158. Zoties Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Vaccine Market Share by Type: 2022 VS 2029
Figure 3. Varicella Vaccine Features
Figure 4. Influenza Vaccine Features
Figure 5. Polio Vaccine Features
Figure 6. Hepatitis A Vaccine Features
Figure 7. Rabies Vaccine Features
Figure 8. BCG Vaccine Features
Figure 9. Hepatitis B Features
Figure 10. Pertussis, Diphtheria, Tetanus Features
Figure 11. Pneumococcal Features
Figure 12. Others Features
Figure 13. Global Vaccine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 14. Global Vaccine Market Share by Application: 2022 VS 2029
Figure 15. For Adult Case Studies
Figure 16. For Child Case Studies
Figure 17. Vaccine Report Years Considered
Figure 18. Global Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Vaccine Market Share by Region: 2022 VS 2029
Figure 21. Global Vaccine Market Share by Players in 2022
Figure 22. Global Top Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Vaccine Revenue in 2022
Figure 24. North America Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Vaccine Market Share by Country (2018-2029)
Figure 26. United States Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Vaccine Market Share by Country (2018-2029)
Figure 30. Germany Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Vaccine Market Share by Region (2018-2029)
Figure 38. China Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Vaccine Market Share by Country (2018-2029)
Figure 46. Mexico Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Vaccine Market Share by Country (2018-2029)
Figure 50. Turkey Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. AstraZeneca Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 53. BioNTech Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 54. Boehringer-Ingelheim Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 55. CCBIO Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 56. CSL Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 57. CureVac Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 58. Elanco Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 59. GSK Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 60. Hulan Bio Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 61. Indian Immunologicals Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 63. Minhai Biotechnology Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 64. Mitsubishi Tanabe Pharma Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 65. Moderna Therapeutics Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 66. Mylan Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 67. Plumbline Life Sciences Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 68. Sanofi Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 69. Translate Bio Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 70. Walvax Biotechnology Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 71. Wuhan Institute of Biological Products Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 72. Zoties Revenue Growth Rate in Vaccine Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Keyplayers in Global Vaccine Market Research Report 2023
AstraZenecaBioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
